Insulet Corp. (PODD)PODDInsulet Corp.

Income Statement

Revenue, expenses, and profitability analysis

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	3.05B	801.70M	761.70M	783.80M	706.30M	649.10M	569.00M	597.50M	543.90M
Cost of Goods Sold	883.20M	239.20M	232.60M	215.20M	196.20M	196.90M	160.00M	166.60M	166.80M
Gross Profit	2.17B	562.50M	529.10M	568.60M	510.10M	452.20M	409.00M	430.90M	377.10M
Gross Profit Margin	71.1%	70.2%	69.5%	72.5%	72.2%	69.7%	71.9%	72.1%	69.3%
Total Operating Expenses	1.65B	433.00M	406.90M	422.30M	392.40M	331.10M	320.20M	321.60M	289.00M
Research & Development	345.90M	88.10M	89.70M	90.90M	77.20M	73.40M	59.60M	60.60M	54.90M
Selling, General & Administrative	1.31B	344.90M	317.20M	331.40M	315.20M	257.70M	260.60M	261.00M	234.10M
Operating Income (EBIT)	515.80M	129.70M	122.10M	146.30M	117.70M	121.10M	88.80M	109.30M	88.10M
Operating Margin	16.9%	16.2%	16.0%	18.7%	16.7%	18.7%	15.6%	18.3%	16.2%
Income Before Tax (EBT)	494.70M	118.70M	113.00M	140.20M	122.80M	28.40M	48.10M	111.30M	82.90M
Interest Income	14.30M	-4.90M	4.90M	5.70M	8.60M	10.10M	10.30M	10.30M	10.50M
Interest Expense	15.60M	-34.30M	14.70M	19.60M	15.60M	19.60M	9.20M	8.70M	12.30M
Other Income/Expense	-21.10M	-11.00M	-9.10M	-6.10M	5.10M	-92.70M	-40.70M	2.00M	-5.20M
Net Income	375.30M	95.00M	91.10M	101.60M	87.60M	22.50M	35.40M	100.70M	77.50M
Income Tax Expense	71.90M	-23.70M	21.90M	38.50M	35.20M	5.90M	12.70M	10.60M	5.40M
Net Profit Margin	12.3%	11.8%	12.0%	13.0%	12.4%	3.5%	6.2%	16.9%	14.2%
EBITDA	431.90M	-33.00M	148.30M	176.90M	139.70M	143.40M	110.50M	130.80M	109.40M
EBITDA Margin	14.1%	-4.1%	19.5%	22.6%	19.8%	22.1%	19.4%	21.9%	20.1%
Depreciation & Amortization	52.60M	-26.20M	26.20M	30.60M	22.00M	22.30M	21.70M	21.50M	21.30M
EPS Basic	5.36	1.37	1.30	1.45	1.24	0.32	0.50	1.44	1.11
EPS Diluted	5.35	1.37	1.30	1.44	1.24	0.32	0.50	1.39	1.08
Shares Outstanding	69.64M	69.64M	69.99M	70.36M	70.65M	70.33M	70.27M	70.16M	70.12M
Diluted Shares Outstanding	69.80M	69.80M	70.20M	70.67M	70.66M	70.64M	74.11M	74.08M	73.95M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	2.71B	2.07B	1.70B	1.31B	1.10B	904.40M	738.20M	563.82M
Cost of Goods Sold	768.20M	625.90M	537.20M	499.70M	346.70M	322.10M	257.90M	193.66M
Gross Profit	1.94B	1.45B	1.16B	805.60M	752.10M	582.30M	480.30M	370.17M
Gross Profit Margin	71.6%	69.8%	68.3%	61.7%	68.4%	64.4%	65.1%	65.7%
Total Operating Expenses	1.47B	1.14B	939.90M	768.00M	626.10M	530.80M	430.30M	342.80M
Research & Development	301.10M	219.60M	205.00M	180.20M	160.10M	146.80M	132.30M	88.61M
Selling, General & Administrative	1.17B	917.20M	734.90M	587.80M	466.00M	384.00M	298.00M	248.00M
Operating Income (EBIT)	473.80M	308.90M	220.00M	37.60M	126.00M	51.50M	50.00M	27.40M
Operating Margin	17.5%	14.9%	13.0%	2.9%	11.5%	5.7%	6.8%	4.9%
Income Before Tax (EBT)	339.50M	300.20M	214.60M	9.80M	20.50M	9.70M	14.50M	5.20M
Interest Income	34.70M	39.50M	28.60M	9.30M	500K	3.00M	N/A	6.71M
Interest Expense	79.70M	42.70M	36.20M	36.00M	61.70M	48.10M	34.60M	22.20M
Other Income/Expense	-134.30M	-8.70M	-5.40M	-27.80M	-105.50M	-41.80M	-35.50M	-22.20M
Net Income	247.10M	418.30M	206.30M	4.60M	16.80M	6.80M	11.60M	3.29M
Income Tax Expense	92.40M	-118.10M	8.30M	5.20M	3.70M	2.90M	2.90M	1.90M
Net Profit Margin	9.1%	20.2%	12.2%	0.4%	1.5%	0.8%	1.6%	0.6%
EBITDA	586.90M	389.70M	292.80M	100.80M	183.40M	106.90M	77.90M	43.00M
EBITDA Margin	21.7%	18.8%	17.3%	7.7%	16.7%	11.8%	10.6%	7.6%
Depreciation & Amortization	113.10M	80.80M	72.80M	63.20M	57.40M	55.40M	27.90M	15.60M
EPS Basic	3.51	5.97	2.96	0.07	0.25	0.11	0.19	0.06
EPS Diluted	3.48	5.78	2.94	0.07	0.25	0.10	0.19	0.05
Shares Outstanding	70.35M	70.08M	69.75M	69.38M	67.70M	64.73M	60.59M	58.86M
Diluted Shares Outstanding	71.89M	73.89M	73.63M	69.91M	68.58M	65.95M	62.30M	61.01M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About Insulet Corp.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Acton, MA

5,400 employees

www.insulet.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Ashley McEvoy

View full financials

Quarterly Report

TTM

Quarter ended Jun 2026

Quarter ended Mar 2026

Quarter ended Dec 2025

Quarter ended Sep 2025

Quarter ended Jun 2025

Quarter ended Mar 2025

Quarter ended Dec 2024

Quarter ended Sep 2024

Revenue

3.05B

801.70M

761.70M

783.80M

706.30M

649.10M

569.00M

597.50M

543.90M

Cost of Goods Sold

883.20M

239.20M

232.60M

215.20M

196.20M

196.90M

160.00M

166.60M

166.80M

Gross Profit

2.17B

562.50M

529.10M

568.60M

510.10M

452.20M

409.00M

430.90M

377.10M

Gross Profit Margin

71.1%

70.2%

69.5%

72.5%

72.2%

69.7%

71.9%

72.1%

69.3%

Total Operating Expenses

1.65B

433.00M

406.90M

422.30M

392.40M

331.10M

320.20M

321.60M

289.00M

Research & Development

345.90M

88.10M

89.70M

90.90M

77.20M

73.40M

59.60M

60.60M

54.90M

Selling, General & Administrative

1.31B

344.90M

317.20M

331.40M

315.20M

257.70M

260.60M

261.00M

234.10M

Operating Income (EBIT)

515.80M

129.70M

122.10M

146.30M

117.70M

121.10M

88.80M

109.30M

88.10M

Operating Margin

16.9%

16.2%

16.0%

18.7%

16.7%

18.7%

15.6%

18.3%

16.2%

Income Before Tax (EBT)

494.70M

118.70M

113.00M

140.20M

122.80M

28.40M

48.10M

111.30M

82.90M

Interest Income

14.30M

-4.90M

4.90M

5.70M

8.60M

10.10M

10.30M

10.50M

Interest Expense

15.60M

-34.30M

14.70M

19.60M

15.60M

19.60M

9.20M

8.70M

12.30M

Other Income/Expense

-21.10M

-11.00M

-9.10M

-6.10M

5.10M

-92.70M

-40.70M

2.00M

-5.20M

Net Income

375.30M

95.00M

91.10M

101.60M

87.60M

22.50M

35.40M

100.70M

77.50M

Income Tax Expense

71.90M

-23.70M

21.90M

38.50M

35.20M

5.90M

12.70M

10.60M

5.40M

Net Profit Margin

12.3%

11.8%

12.0%

13.0%

12.4%

3.5%

6.2%

16.9%

14.2%

EBITDA

431.90M

-33.00M

148.30M

176.90M

139.70M

143.40M

110.50M

130.80M

109.40M

EBITDA Margin

14.1%

-4.1%

19.5%

22.6%

19.8%

22.1%

19.4%

21.9%

20.1%

Depreciation & Amortization

52.60M

-26.20M

26.20M

30.60M

22.00M

22.30M

21.70M

21.50M

21.30M

EPS Basic

5.36

1.37

1.30

1.45

1.24

0.32

0.50

1.44

1.11

EPS Diluted

5.35

1.37

1.30

1.44

1.24

0.32

0.50

1.39

1.08

Shares Outstanding

69.64M

69.99M

70.36M

70.65M

70.33M

70.27M

70.16M

70.12M

Diluted Shares Outstanding

69.80M

70.20M

70.67M

70.66M

70.64M

74.11M

74.08M

73.95M

Annual Report

12/31/2025

12/31/2024

12/31/2023

12/31/2022

12/31/2021

12/31/2020

12/31/2019

12/31/2018

Revenue

2.71B

2.07B

1.70B

1.31B

1.10B

904.40M

738.20M

563.82M

Cost of Goods Sold

768.20M

625.90M

537.20M

499.70M

346.70M

322.10M

257.90M

193.66M

Gross Profit

1.94B

1.45B

1.16B

805.60M

752.10M

582.30M

480.30M

370.17M

Gross Profit Margin

71.6%

69.8%

68.3%

61.7%

68.4%

64.4%

65.1%

65.7%

Total Operating Expenses

1.47B

1.14B

939.90M

768.00M

626.10M

530.80M

430.30M

342.80M

Research & Development

301.10M

219.60M

205.00M

180.20M

160.10M

146.80M

132.30M

88.61M

Selling, General & Administrative

1.17B

917.20M

734.90M

587.80M

466.00M

384.00M

298.00M

248.00M

Operating Income (EBIT)

473.80M

308.90M

220.00M

37.60M

126.00M

51.50M

50.00M

27.40M

Operating Margin

17.5%

14.9%

13.0%

2.9%

11.5%

5.7%

6.8%

4.9%

Income Before Tax (EBT)

339.50M

300.20M

214.60M

9.80M

20.50M

9.70M

14.50M

5.20M

Interest Income

34.70M

39.50M

28.60M

9.30M

500K

3.00M

N/A

6.71M

Interest Expense

79.70M

42.70M

36.20M

36.00M

61.70M

48.10M

34.60M

22.20M

Other Income/Expense

-134.30M

-8.70M

-5.40M

-27.80M

-105.50M

-41.80M

-35.50M

-22.20M

Net Income

247.10M

418.30M

206.30M

4.60M

16.80M

6.80M

11.60M

3.29M

Income Tax Expense

92.40M

-118.10M

8.30M

5.20M

3.70M

2.90M

1.90M

Net Profit Margin

9.1%

20.2%

12.2%

0.4%

1.5%

0.8%

1.6%

0.6%

EBITDA

586.90M

389.70M

292.80M

100.80M

183.40M

106.90M

77.90M

43.00M

EBITDA Margin

21.7%

18.8%

17.3%

7.7%

16.7%

11.8%

10.6%

7.6%

Depreciation & Amortization

113.10M

80.80M

72.80M

63.20M

57.40M

55.40M

27.90M

15.60M

EPS Basic

3.51

5.97

2.96

0.07

0.25

0.11

0.19

0.06

EPS Diluted

3.48

5.78

2.94

0.07

0.25

0.10

0.19

0.05

Shares Outstanding

70.35M

70.08M

69.75M

69.38M

67.70M

64.73M

60.59M

58.86M

Diluted Shares Outstanding

71.89M

73.89M

73.63M

69.91M

68.58M

65.95M

62.30M

61.01M